Most recently, it has been discovered that conolidine and the above derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in identical places as classical opioid receptors, it binds to a wide array of endogenous opioids. As opposed to most opioid receptors, this receptor functions for a scavenger and doesn't activate a second me… Read More